(Total Views: 767)
Posted On: 09/23/2020 1:20:28 PM
Post# of 154874
Here are more detailed reasons why Dr. Yo does not think experimental drugs will be used for longhaulers. It essentially comes down to accessibility not efficacy.
Link
I disagree in that the playing field could change and these drugs may become subsidized and the best solution. No one knows how this plays out.
Quote:
It is not going to play a role in long haulers. Neither is leronlimab or lenzilumab. 1. approval 2. cost. A lot more research needs to be done before experimental drugs can be considered for long haulers. Maybe for next pandemic (hopefully we don't see another pandemic)
Link
I disagree in that the playing field could change and these drugs may become subsidized and the best solution. No one knows how this plays out.
(2)
(0)
